This study aimed to evaluate the current management of tinea capitis in the United States, specifically focusing on patients aged 0-2 months, 2 months to 2 years, and 2 years to 18 years. An online survey, distributed through the Pediatric Dermatology Research Alliance and the Society of Pediatric Dermatology, revealed the following preferences: fluconazole for those under 2 months, griseofulvin for those aged 2 months to 2 years, and terbinafine for those aged 2 years and older. There exists inter-provider variation in tinea capitis treatment regimens within the pediatric dermatology community.
All Keywords
【저자키워드】 Fungal infection, Dermatomycoses, hair disorders, bacterial infections and mycoses, infectious skin diseases.,
【저자키워드】 Fungal infection, Dermatomycoses, hair disorders, bacterial infections and mycoses, infectious skin diseases.,